A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 18 Issue 3 October 2024) has been published and includes articles on:
GLP-1 receptor agonists: reminder of the potential side effects and to be aware of the potential for misuse.
Insulin pumps and continuous glucose monitoring (CGM) equipment: guidance for users on reporting suspected adverse incidents and safety concerns to the MHRA’s Yellow Card scheme.
Bromocriptine: monitor blood pressure when prescribing bromocriptine for prevention or inhibition of post-partum physiological lactation.
Letters and medicine recalls sent to healthcare professionals in September 2024
To see the latest MHRA Drug Safety Updates in full, visit the GOV.uk website.
The post MHRA: Drug Safety Update: October 2024 appeared first on Community Pharmacy England.